Evidence map›Paper›PMID 29967194›Full record

ArticleAnnals of the rheumatic diseases2018

Systematic approach demonstrates enrichment of multiple interactions between non-

Lina-Marcela Diaz-Gallo, Daniel Ramsköld, Klementy Shchetynsky, Lasse Folkersen, Karine Chemin, Boel Brynedal, Steffen Uebe, Yukinori Okada, Lars Alfredsson, Lars Klareskog and 1 more

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in Annals of the rheumatic diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Association ofFrontiers in immunology · 2021
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Genetics of rheumatoid arthritis.Seminars in immunopathology · 2022
    Review
  6. Review
  7. Review
  8. Interaction of HLA Class II rs9272219 andFrontiers in genetics · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Lina-Marcela Diaz-GalloRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-5688-0102
Daniel RamsköldRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0003-2892-673X
Klementy ShchetynskyRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0003-4578-5588
Lasse FolkersenSankt Hans Hospital, Capital Region Hospitals, Roskilde, Denmark.
Karine CheminRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Boel BrynedalInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Steffen UebeHuman Genetics Institute, Universitätsklinikum Erlangen, Erlangen, Germany.
Yukinori OkadaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan.
Lars AlfredssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Lars KlareskogRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Leonid PadyukovRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0003-2950-5670
Karolinska University Hospital · SEKarolinska Institutet · SESankt Hans Hospital · DKThe University of Osaka · JPUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn anti-citrullinated protein antibody positive rheumatoid arthritis (ACPA-positive RA), a particular subset of

methodsWe computed the attributable proportion (AP) due to additive interaction at genome-wide level for two independent ACPA-positive RA cohorts: the Swedish epidemiological investigation of rheumatoid arthritis (EIRA) and the North American rheumatoid arthritis consortium (NARAC). Then, we tested for differences in the AP p value distributions observed for two groups of SNPs, non-associated and associated with disease. We also evaluated whether the SNPs in interaction with

resultsWe found a strong enrichment of significant interactions (AP p<0.05) between the

conclusionOur data demonstrate that there are massive genetic interactions between the

Indexed as

AllelesAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidCohort StudiesEpistasis, GeneticEpitopesFemaleGenetic Predisposition to DiseaseHLA-DRB1 ChainsHumansMaleNorth AmericaPolymorphism, Single NucleotideRisk FactorsSwedenAnti-Citrullinated Protein AntibodiesEpitopesHLA-DRB1 ChainsANT-CCPgene polymorphismrheumatoid arthritis

Identifiers

PMID29967194
PMCPMC6161669
OpenAlexW2809963516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.